psychoneuro, Table of Contents psychoneuro 2008; 34(3): 162-163DOI: 10.1055/s-2008-1076633 Blickpunkt © Georg Thieme Verlag KG Stuttgart · New YorkSchizophrenie - 1x täglich für eine bessere ComplianceRecommend Article Abstract Full Text References Literatur 01 Kahn RS . et al . Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007; 68 (6) 832-842 02 McEvoy JP . et al . Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison. Am J Psychiatry. 2007; 164 (7) 1050-1060 03 Peuskens J . et al . Prevention of schizophrenia relapse with extended release quetiapine fumarate doesed once daily: A randomized, placebo-controlled trial in clinically stable patients. Psychiatry. 2007; 4 (11) 34-50 04 Robinson D . et al . Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999; 56 (3) 241-247